Fernanda Fabiani

916 total citations
21 papers, 731 citations indexed

About

Fernanda Fabiani is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Fernanda Fabiani has authored 21 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Fernanda Fabiani's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Tuberous Sclerosis Complex Research (2 papers) and Skin and Cellular Biology Research (2 papers). Fernanda Fabiani is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Tuberous Sclerosis Complex Research (2 papers) and Skin and Cellular Biology Research (2 papers). Fernanda Fabiani collaborates with scholars based in Italy, United States and Russia. Fernanda Fabiani's co-authors include Giuseppe Viglietto, Carmela De Marco, Renato Franco, Marianna Scrima, Donatella Malanga, Giuseppe Pirozzi, Gaetano Rocco, Pierfrancesco Tassone, Maria Teresa Di Martino and Michele Caraglia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Fernanda Fabiani

20 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernanda Fabiani Italy 11 525 184 182 154 107 21 731
Carla Kurkjian United States 17 481 0.9× 130 0.7× 302 1.7× 157 1.0× 101 0.9× 41 830
Evangelos Bournakis Greece 15 272 0.5× 153 0.8× 267 1.5× 160 1.0× 66 0.6× 35 621
William Dahut United States 11 464 0.9× 190 1.0× 323 1.8× 287 1.9× 81 0.8× 19 887
Laura Carrassa Italy 21 874 1.7× 180 1.0× 511 2.8× 169 1.1× 106 1.0× 35 1.1k
Takafumi Koyama Japan 19 293 0.6× 144 0.8× 447 2.5× 168 1.1× 103 1.0× 87 871
Raymond Wadlow United States 14 484 0.9× 196 1.1× 485 2.7× 179 1.2× 110 1.0× 36 944
Fabien Calvo France 7 761 1.4× 418 2.3× 345 1.9× 199 1.3× 216 2.0× 13 1.4k
Nicoletta Staropoli Italy 14 233 0.4× 111 0.6× 350 1.9× 112 0.7× 56 0.5× 42 617
Luis T. Campos United States 13 201 0.4× 140 0.8× 441 2.4× 145 0.9× 114 1.1× 29 726
Christopher Ruel United States 18 468 0.9× 131 0.7× 536 2.9× 309 2.0× 53 0.5× 47 1.0k

Countries citing papers authored by Fernanda Fabiani

Since Specialization
Citations

This map shows the geographic impact of Fernanda Fabiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernanda Fabiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernanda Fabiani more than expected).

Fields of papers citing papers by Fernanda Fabiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernanda Fabiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernanda Fabiani. The network helps show where Fernanda Fabiani may publish in the future.

Co-authorship network of co-authors of Fernanda Fabiani

This figure shows the co-authorship network connecting the top 25 collaborators of Fernanda Fabiani. A scholar is included among the top collaborators of Fernanda Fabiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernanda Fabiani. Fernanda Fabiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Antona, Lucia, Fernanda Fabiani, Rosario Amato, et al.. (2025). Hereditary Transthyretin Amyloidosis: Genetic Characterization of the TTR P.Val142Ile Variant in a Calabrian Kindred. Genes. 16(8). 960–960.
2.
Paduano, Francesco, Fernanda Fabiani, Lucia D’Antona, et al.. (2022). Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy. Genes. 13(7). 1286–1286. 6 indexed citations
3.
Paduano, Francesco, Rosario Amato, Steven Paul Nisticò, et al.. (2021). A Familial Form of Epidermolysis Bullosa Simplex Associated with a Pathogenic Variant in KRT5. Genes. 12(10). 1503–1503. 1 indexed citations
4.
D’Aquila, Patrizia, Domenica Ronchetti, Maria Eugenia Gallo Cantafio, et al.. (2021). Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs. Journal of Clinical Medicine. 10(6). 1295–1295. 8 indexed citations
5.
Paduano, Francesco, Fernanda Fabiani, Francesco Trapasso, et al.. (2021). Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome. Frontiers in Genetics. 12. 734809–734809. 4 indexed citations
6.
Arbitrio, Mariamena, Francesca Scionti, Emanuela Altomare, et al.. (2019). Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study. Clinical Pharmacology & Therapeutics. 106(2). 422–431. 23 indexed citations
7.
Marascio, Nadia, Grazia Pavia, Isabella Romeo, et al.. (2018). Real‐life 3D therapy failure: Analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling. Journal of Medical Virology. 90(7). 1257–1263. 11 indexed citations
8.
Menniti, Miranda, et al.. (2016). New SLC12A3 disease causative mutation of Gitelman’s syndrome. World Journal of Nephrology. 5(6). 551–551. 1 indexed citations
9.
Fabiani, Fernanda, et al.. (2015). The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: Presentation of an inbred family and a novel truncating mutation in exon 3. SHILAP Revista de lepidopterología. 16. 77–80. 10 indexed citations
10.
Zicca, Emilia, Angela Quirino, Nadia Marascio, et al.. (2014). Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?. BMC Infectious Diseases. 14(S5). S5–S5. 8 indexed citations
11.
Marco, Carmela De, Paola Bruni, Carmine Malzoni, et al.. (2013). Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma. PLoS ONE. 8(2). e55362–e55362. 31 indexed citations
12.
Scrima, Marianna, Carmela De Marco, Fernanda Fabiani, et al.. (2012). Signaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase. PLoS ONE. 7(2). e30427–e30427. 101 indexed citations
13.
Scrima, Marianna, Carmela De Marco, Fernanda Fabiani, et al.. (2012). The Nonreceptor-Type Tyrosine Phosphatase PTPN13 Is a Tumor Suppressor Gene in Non–Small Cell Lung Cancer. American Journal Of Pathology. 180(3). 1202–1214. 55 indexed citations
14.
Amodio, Nicola, Maria Teresa Di Martino, Umberto Foresta, et al.. (2012). MiR-29b Exerts Anti-Multiple Myeloma Activity by Targeting Key Oncogenic Pathways and Modulating DNA Methylation Profile.. Blood. 120(21). 2941–2941. 1 indexed citations
15.
Amodio, Nicola, Marzia Leotta, Dina Bellizzi, et al.. (2012). DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. Oncotarget. 3(10). 1246–1258. 126 indexed citations
16.
Martino, Maria Teresa Di, Mariamena Arbitrio, Emanuela Leone, et al.. (2011). Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: A DMET microarray profiling study. Cancer Biology & Therapy. 12(9). 780–787. 72 indexed citations
17.
Malanga, Donatella, Marianna Scrima, Carmela De Marco, et al.. (2008). Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung. Cell Cycle. 7(5). 665–669. 146 indexed citations
18.
Motti, Maria Letizia, Carmela De Marco, Daniela Califano, et al.. (2007). Loss of p27 Expression Through RAS->BRAF->MAP Kinase-Dependent Pathway in Human Thyroid Carcinomas. Cell Cycle. 6(22). 2817–2825. 23 indexed citations
19.
Vizio, Dolores Di, Letizia Cito, Angelo Boccia, et al.. (2005). Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene. 24(11). 1882–1894. 97 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Kurkjian Breakdown of academic impact, for papers by Evangelos Bournakis Breakdown of academic impact, for papers by William Dahut Breakdown of academic impact, for papers by Laura Carrassa Breakdown of academic impact, for papers by Takafumi Koyama Breakdown of academic impact, for papers by Raymond Wadlow Breakdown of academic impact, for papers by Fabien Calvo Breakdown of academic impact, for papers by Nicoletta Staropoli Breakdown of academic impact, for papers by Luis T. Campos Breakdown of academic impact, for papers by Christopher Ruel
Rankless by CCL
2026